Why the study?
Donor shortage limits heart transplantation, and while donors with Wolff-Parkinson-White syndrome are usually discarded, optimal recipient management strategies remain controversial.
Can hearts from donors with Wolff-Parkinson-White syndrome be successfully used for heart transplantation?
Can hearts from donors with Wolff-Parkinson-White syndrome be successfully used for heart transplantation?
Hearts from donors with Wolff-Parkinson-White syndrome can be successfully transplanted, with arrhythmias manageable via clinical treatment or ablation.
Transplantation from WPWS donors appears feasible in case reports; leaves open whether this safely expands the donor pool.
Donor shortage is a major limitation of heart transplantation. The use of high risk or marginal donors, donors with minor or correctable heart diseases are alternatives to face this problem. When identified in the evaluation, donors with Wolff-Parkinson-White syndrome (WPWS) are usually discarded for cardiac transplantation. In the literature, there are eight articles reporting single case of transplantation with donor with this syndrome. In this series, the management of recipient varied: clinical treatment, intraoperative donor heart anomalous band ablation and postoperative ablation. Results were good in all the eight cases. In the present article, we report two cases of cardiac transplantation with donors with WPWS, one treated clinically and the other one submitted to postoperative ablation. Based in the present experience and limited to eight reported cases, it seems that this type of donor heart can be successfully transplanted. It is controversial the management strategy for these patients. Careful evaluation of heart donor should be done regarding the presence of WPWS.
No takes yet. Share an insight, caveat, or question.
Solf et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: